Preparing for a novel era in CV prevention: Where do PCSK9 inhibitors fit in lipid management? - PACE-CME

Preparing for a novel era in CV prevention Where do PCSK inhibitors fit in lipid management

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Mendelian randomisation study suggests that CV prevention could be simpler and more effective
Mendelian randomisation study suggests that CV prevention could be simpler and more effective
ESC 2016
Mendelian randomisation study suggests that CV prevention could be simpler and more effective
- Dr. Brian Ference
No indication for difference in efficacy between potent platelet inhibitors after PCI
No indication for difference in efficacy between potent platelet inhibitors after PCI
ESC 2016
No indication for difference in efficacy between potent platelet inhibitors after PCI
- Steen Dalby Kristensen, MD
Heart failure news at the ESC
Heart failure news at the ESC
ESC 2016
Heart failure news at the ESC
- Frank Ruschitzka, MD
Would lower than the current ApoB targets be more useful for clinical decision-making?
Would lower than the current ApoB targets be more useful for clinical decision-making?
CSI 2016 ESC
Would lower than the current ApoB targets be more useful for clinical decision-making?
- Seth Shay Martin, MD